Form 4 for ELV Elevance Health
Accepted 2026-03-04 00:00:00 ET · period of report 2026-03-02 · accession 0001287920-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-04 | 2026-03-02+ | ELV | BOUDREAUX GAIL | Pres, CEO, Dir | F - Tax | $292.01 | -8,449 | 169.3K | -5% | -$2.47M |
| DM | 2026-03-04 | 2026-03-02 | ELV | BOUDREAUX GAIL | Pres, CEO, Dir | A - Grant | $0.00 | +26.7K | 171.0K | +18% | $0 |
| D | 2026-03-04 | 2026-03-02 | ELV | BOUDREAUX GAIL | Pres, CEO, Dir | A - Grant | $0.00 | +63.8K | 63.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-02 | F | D | 6,713 | $294.07 | 144,307 | D | — | — | (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. |
| 2 | Common | Common Stock | 2026-03-02 | A | A | 16,153 | $0.00 | 160,460 | D | — | — | (F2) Represents restricted share units. Restrictions lapse as follows: 5,384 shares each on 3/2/2027 and 3/2/2028 and 5,385 shares on 3/2/2029. |
| 3 | Common | Common Stock | 2026-03-02 | A | A | 10,527 | $0.00 | 170,987 | D | — | — | (F3) Represents performance based restricted share units. Restrictions lapsed on 3/2/2026. |
| 4 | Common | Common Stock | 2026-03-03 | F | D | 1,736 | $284.03 | 169,251 | D | — | — | (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2026-03-02 | A | A | 63,818 | $0.00 | 63,818 | D | $294.07 · — to 2036-03-02 | 63,818 Common Stock | (F4) The option represents a right to purchase a total of 63,818 shares, and is exercisable in three annual installments, with one installment of 21,272 shares and two installments of 21,273 shares each, beginning on 3/2/2027, which is the one-year anniversary of the option grant date. |